- Home
- ONBPO vs INM Comparison
ONBPO vs INM Comparison
Compare ONBPO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONBPO
- INM
- Stock Information
- Founded
- ONBPO N/A
- INM 1981
- Country
- ONBPO United States
- INM Canada
- Employees
- ONBPO 5313
- INM N/A
- Industry
- ONBPO Major Banks
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ONBPO Finance
- INM Health Care
- Exchange
- ONBPO Nasdaq
- INM Nasdaq
- Market Cap
- ONBPO N/A
- INM 5.1M
- IPO Year
- ONBPO N/A
- INM N/A
- Fundamental
- Price
- ONBPO $25.35
- INM $2.17
- Analyst Decision
- ONBPO
- INM
- Analyst Count
- ONBPO 0
- INM 0
- Target Price
- ONBPO N/A
- INM N/A
- AVG Volume (30 Days)
- ONBPO N/A
- INM 125.1K
- Earning Date
- ONBPO N/A
- INM 11-13-2025
- Dividend Yield
- ONBPO N/A
- INM N/A
- EPS Growth
- ONBPO N/A
- INM N/A
- EPS
- ONBPO N/A
- INM N/A
- Revenue
- ONBPO N/A
- INM $4,942,633.00
- Revenue This Year
- ONBPO N/A
- INM N/A
- Revenue Next Year
- ONBPO N/A
- INM N/A
- P/E Ratio
- ONBPO N/A
- INM N/A
- Revenue Growth
- ONBPO N/A
- INM 7.50
- 52 Week Low
- ONBPO N/A
- INM $1.72
- 52 Week High
- ONBPO N/A
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- ONBPO 55.88
- INM 48.50
- Support Level
- ONBPO $25.09
- INM $2.12
- Resistance Level
- ONBPO $25.19
- INM $2.24
- Average True Range (ATR)
- ONBPO 0.13
- INM 0.13
- MACD
- ONBPO -0.00
- INM -0.00
- Stochastic Oscillator
- ONBPO 81.51
- INM 39.14
About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.